Lecanemab: Drug Developed to Treat Alzheimer’s Slows Progression of Disease
Researchers have heralded Lecanemab, a drug that slows the destruction of the human brain due to Alzheimer's disease. Alzheimer's disease is the most common form of dementia and the Lecanemab has ushered in a new era of drugs that could treat the disease
Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus
An experimental Alzheimer's drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of serious side effects for certain patients, according to detailed data presented on Tuesday.
Drug slows Alzheimer's but can it make a real difference?
An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening, researchers reported Tuesday – but it remains unclear how much difference that might make in people's lives.
Alzheimer's drug slowed cognitive decline overall in trial, but with major side effects for some
An experimental Alzheimer's disease drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients, according to new data presented on Tuesday.